Flow Cytometry In Oncology And Immunology Market Expansion Continues, with Forecast Valuation of $3.45 Billion by 2029

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Flow Cytometry In Oncology And Immunology Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The overall valuation of the flow cytometry market within the oncology and immunology sectors has experienced substantial expansion lately, projected to increase from $2.11 billion in 2024 to $2.32 billion in the subsequent year, reflecting a compound annual growth rate (CAGR) of 10.1%; this upward trajectory during the past period resulted from progress in cancer studies, the expansion of immunology research efforts, wider diagnostic uses, an increase in instances of autoimmune disorders, and heightened activity in pharmaceutical development and clinical testing.

Flow Cytometry In Oncology And Immunology Market Size Forecast: What's the Projected Valuation by 2029?
Anticipated vigorous expansion is projected for the flow cytometry in oncology and immunology market over the approaching years, with its valuation set to reach $3.45 billion by 2029, reflecting a compound annual growth rate (CAGR) of 10.4%. This upswing across the projection timeline is fundamentally driven by several factors, including the increasing amalgamation with genomic and proteomic research, broader uptake of single-cell analytical techniques, widening utility within the realm of infectious disease management, the escalating occurrence of cancer cases, and the development of point-of-care flow cytometry solutions. Key developments shaping this market during the forecast period encompass the utilization of immunophenotyping to advance immunotherapy strategies, the trend towards shrinking the physical footprint of flow cytometry apparatus, the increasing capability for multiparametric analysis, a discernible movement toward adopting spectral flow cytometry methodologies, and the fostering of joint research efforts across the industry.

View the full report here:
https://www.thebusinessresearchcompany.com/report/flow-cytometry-in-oncology-and-immunology-global-market-report

What Are the Drivers Transforming the Flow Cytometry In Oncology And Immunology Market?
Anticipated expansion in cancer incidence is poised to stimulate the advancement of flow cytometry within the markets pertaining to oncology and immunology as we move ahead. Cancer, defined as a collection of conditions marked by the unrestrained multiplication and dissemination of aberrant cells within an organism, is the focus of flow cytometry, a technique frequently employed in both oncology and immunology for the examination of cancer and immune cells. To illustrate this trend, data from Macmillan Cancer Support in the UK indicated that in 2020, three million individuals were living with cancer, with projections suggesting this number will escalate to 3.5 million by 2025, four million by 2030, and ultimately 5.3 million by 2040; consequently, this rising frequency of cancer cases is acting as a catalyst for the expansion of flow cytometry applications in the oncology and immunology sectors.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12469&type=smp

What Long-Term Trends Will Define the Future of the Flow Cytometry In Oncology And Immunology Market?
A significant trend impacting the flow cytometry sector within the oncology and immunology sphere is the rapid pace of technological progress. Key players in this market are actively integrating novel technologies to solidify and maintain their competitive standing. As an illustration of this movement, in September of 2022, the American medical technology firm, Becton dic*kinson and Company, released BD Research Cloud, specifically tailored for flow cytometry applications in both oncology and immunology. This cloud-based software facilitates a streamlined flow cytometry workflow for investigators across diverse disciplines, including immunology, virology, infectious disease research, and cancer monitoring, ultimately speeding up the journey to discovery and yielding superior research outcomes. Furthermore, BD is capitalizing on cutting-edge innovations such as the BD Horizon RealYellow and RealBlue Reagents, alongside the recent debut of the BD FACSDiscover S8 Cell Sorter featuring BD CellView Image Technology, thereby augmenting flow cytometry's potential and empowering scientists to refine and progress their essential research endeavors. This BD Research Cloud, constructed upon a widely accepted cloud framework, offers seamless compatibility with established BD instrumentation and associated reagents.

Which Segments in the Flow Cytometry In Oncology And Immunology Market Offer the Most Profit Potential?
The flow cytometry in oncology and immunologymarket covered in this report is segmented -

1) By Type: Immunology; Oncology
2) By Technology: Cell-Based Flow Cytometry; Bead-Based Flow Cytometry
3) By Application: Translational Research; Clinical Research
4) By End User: Hospitals; Diagnostic Laboratories; Reference Laboratories; Pharmaceutical And Biotechnology Companies; Academic Research Institutes; Contract Research Organizations; Other End Users

Subsegments:
1) By Immunology: Immune Cell Profiling; Cytokine Detection; T-Cell And B-Cell Analysis; Autoimmune Disease Testing
2) By Oncology: Cancer Cell Analysis; Tumor Microenvironment Studies; Minimal Residual Disease Detection; Biomarker Discovery And Validation

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12469&type=smp

Which Firms Dominate the Flow Cytometry In Oncology And Immunology Market by Market Share and Revenue in 2025?
Major companies operating in the flow cytometry in oncology and immunology market include Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton dic*kinson and Company, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Sartorius AG, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Sysmex Partec GmbH, OPKO Health Inc., Miltenyi Biotec, NeoGenomics Laboratories Inc., Luminex Corporation, Q2 Solutions LLC, DiaSorin S.p.A, BioLegend Inc., Cytek Biosciences Inc., Cell Signaling Technology Inc., Standard BioTools Inc., Sony Biotechnology Inc., NanoCellect Biomedical Inc., Nexcelom Bioscience LLC, CytoReason

Which Regions Offer the Highest Growth Potential in the Flow Cytometry In Oncology And Immunology Market?
North America was the largest region in the flow cytometry in oncology and immunology market in 2024. The regions covered in the flow cytometry in oncology and immunology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12469

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.